GOVX
Price:
$2.195
Market Cap:
$20.71M
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Preve...[Read more]
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
GOVX
According to GeoVax Labs, Inc.’s latest financial reports and current stock price. The company's current ROE is -809.91%. This represents a change of -69.89% compared to the average of -2689.88% of the last 4 quarters.
The mean historical ROE of GeoVax Labs, Inc. over the last ten years is -170.44%. The current -809.91% ROE has changed 375.20% with respect to the historical average. Over the past ten years (40 quarters), GOVX's ROE was at its highest in in the March 2018 quarter at 482.43%. The ROE was at its lowest in in the March 2024 quarter at -10778.69%.
Average
-170.44%
Median
-137.97%
Minimum
-1361.11%
Maximum
675.94%
Discovering the peaks and valleys of GeoVax Labs, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.28%
Maximum Annual ROE = 675.94%
Minimum Annual Increase = -149.66%
Minimum Annual ROE = -1361.11%
Year | ROE | Change |
---|---|---|
2023 | -450.55% | 755.16% |
2022 | -52.69% | -87.60% |
2021 | -424.84% | 1.28% |
2020 | -30.71% | -120.36% |
2019 | 150.84% | -39.78% |
2018 | 250.49% | -62.94% |
2017 | 675.94% | -149.66% |
2016 | -1361.11% | 509.68% |
2015 | -223.25% | -6.39% |
2014 | -238.49% | 163.78% |
The current ROE of GeoVax Labs, Inc. (GOVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-309.36%
5-year avg
-161.59%
10-year avg
-170.44%
GeoVax Labs, Inc.’s ROE is less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Zura Bio Limited (-39.61%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than 180 Life Sciences Corp. (-559.06%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), less than Kiromic BioPharma, Inc. (327.18%), less than Apexigen, Inc. (48.27%), less than Altamira Therapeutics Ltd. (783.37%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than PaxMedica, Inc. Common Stock (-3167.06%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Jaguar Health, Inc. (-287.85%), less than Onconova Therapeutics, Inc. (619.75%), greater than iBio, Inc. (-126.61%), greater than Ocugen, Inc. (-154.75%),
Company | ROE | Market cap |
---|---|---|
2.18% | $941.00 | |
-130.35% | $206.50K | |
-39.61% | $156.70M | |
-173.56% | $10.01K | |
-25512.50% | $2.81M | |
-134.57% | $2.16M | |
-383.41% | $4.43M | |
-559.06% | $3.75M | |
-258.81% | $40.84M | |
327.18% | $1.42M | |
48.27% | $9.57M | |
783.37% | $1.13M | |
-473.61% | $3.70M | |
-126.19% | $2.78M | |
-126.11% | $3.41M | |
-3167.06% | $761.54K | |
-311.33% | $2.49M | |
-172.28% | $4.17M | |
-287.85% | $11.41M | |
619.75% | $20.90M | |
-126.61% | $22.05M | |
-154.75% | $213.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeoVax Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeoVax Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GeoVax Labs, Inc.'s ROE?
How is the ROE calculated for GeoVax Labs, Inc. (GOVX)?
What is the highest ROE for GeoVax Labs, Inc. (GOVX)?
What is the 3-year average ROE for GeoVax Labs, Inc. (GOVX)?
What is the 5-year average ROE for GeoVax Labs, Inc. (GOVX)?
How does the current ROE for GeoVax Labs, Inc. (GOVX) compare to its historical average?